[Correspondence] Perspective on proton beam therapy for oropharyngeal cancer

The TORPEdO trial1 represents a landmark contribution to oropharyngeal cancer management, demonstrating similar late quality-of-life outcomes between intensity-modulated proton therapy (IMPT) and intensity-modulated radiotherapy (IMRT).

However, as head and neck surgeons involved in the salvage of recurrent disease, we wish to draw attention to a signal deserving closer scrutiny. ...